Background: Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder that requires advanced diagnostic strategies for early and accurate
detection.
Methods: This study introduces a hybrid AI-driven diagnostic framework that
integrates an Artificial Neural Network (ANN) trained on clinical data from 1,200
patients using 31 demographic, symptomatic, and behavioral features with a
Convolutional Neural Network (CNN) trained on 4,876 MRI images to classify
AD into four stages.
Results and Discussion: The ANN achieved an accuracy of 87.08% in earlystage
risk prediction, while the CNN demonstrated a superior 97% accuracy in
disease staging, supported by Grad-CAM visualizations that improved model
interpretability. This dual-model approach effectively combines structured
clinical data with imaging-based analysis, addressing the sensitivity and scalability
limitations of traditional diagnostic methods and providing a more comprehensive
assessment of AD.
Conclusion: The integration of ANN and CNN enhances diagnostic precision
and supports AI-assisted clinical decision-making, with future work focusing on
lightweight CNN architectures and wearable technologies to enable broader
accessibility and earlier intervention
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.